Actualités LifeMD Inc - LFMD | Actions NASDAQ

LifeMD to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual...

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

NEW YORK, Dec. 24, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual...

LifeMD to Participate in the Mizuho Health Care Conference: Medical Device, Services, Technology and Distribution

NEW YORK, Dec. 05, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual...

LifeMD to Participate in Three Investor Conferences During November

NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual...

LifeMD Reports Third Quarter 2024 Results

Total revenues increased 38% year-over-year to $53.4 million with telehealth revenue up 65%Record gross margin...

LifeMD® Launches Affiliated Pharmacy to Drive End-to-End Patient Care and Operational Efficiency

NEW YORK, Nov. 06, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual...

LifeMD® to Report Third Quarter 2024 Financial Results on November 7

NEW YORK, Oct. 24, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual...

LifeMD® Launches TestoRx, a New Rex MD® Direct-to-Consumer Testosterone Replacement Therapy Telehealth Offering

NEW YORK, Oct. 23, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual...

LifeMD® Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

NEW YORK, Sept. 24, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual...

LifeMD Announces Major Enhancements to its Weight Management Program, Expanding Patient Access to Branded GLP-1 Therapies and Introducing New Treatment Options

NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc.® (Nasdaq: LFMD), a leading provider of virtual...

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

LifeMD Inc (LFMD)

Votre Hub pour des idées et discussions en direct en temps réel

LFMD Actualités

LifeMD to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

LifeMD to Participate in the Mizuho Health Care Conference: Medical Device, Services, Technology and Distribution

LifeMD to Participate in Three Investor Conferences During November

LifeMD Reports Third Quarter 2024 Results

LifeMD® Launches Affiliated Pharmacy to Drive End-to-End Patient Care and Operational Efficiency

LifeMD® to Report Third Quarter 2024 Financial Results on November 7

LifeMD® Launches TestoRx, a New Rex MD® Direct-to-Consumer Testosterone Replacement Therapy Telehealth Offering

LifeMD® Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

LifeMD Announces Major Enhancements to its Weight Management Program, Expanding Patient Access to Branded GLP-1 Therapies and Introducing New Treatment Options

LifeMD to Participate in Three Investor Conferences During September

LifeMD Reports Second Quarter 2024 Results

LifeMD to Report Second Quarter 2024 Financial Results on August 7

LifeMD to Participate in Two Investor Conferences During August

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

LifeMD Inc (LFMD) Actualités

LifeMD Inc (LFMD)

Votre Hub pour des idées et discussions en direct en temps réel

LFMD Actualités

LifeMD to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

LifeMD to Participate in the Mizuho Health Care Conference: Medical Device, Services, Technology and Distribution

LifeMD to Participate in Three Investor Conferences During November

LifeMD Reports Third Quarter 2024 Results

LifeMD® Launches Affiliated Pharmacy to Drive End-to-End Patient Care and Operational Efficiency

LifeMD® to Report Third Quarter 2024 Financial Results on November 7

LifeMD® Launches TestoRx, a New Rex MD® Direct-to-Consumer Testosterone Replacement Therapy Telehealth Offering

LifeMD® Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

LifeMD Announces Major Enhancements to its Weight Management Program, Expanding Patient Access to Branded GLP-1 Therapies and Introducing New Treatment Options

LifeMD to Participate in Three Investor Conferences During September

LifeMD Reports Second Quarter 2024 Results

LifeMD to Report Second Quarter 2024 Financial Results on August 7

LifeMD to Participate in Two Investor Conferences During August

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités